99 related articles for article (PubMed ID: 27169445)
1. [Analysis of gene expression and DNA methylation patterns in childhood acute lymphoblastic leukemia].
Iijima K; Kiyokawa N
Rinsho Ketsueki; 2016 Apr; 57(4):425-9. PubMed ID: 27169445
[TBL] [Abstract][Full Text] [Related]
2. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia.
Gabriel AS; Lafta FM; Schwalbe EC; Nakjang S; Cockell SJ; Iliasova A; Enshaei A; Schwab C; Rand V; Clifford SC; Kinsey SE; Mitchell CD; Vora A; Harrison CJ; Moorman AV; Strathdee G
Epigenetics; 2015; 10(8):717-26. PubMed ID: 26237075
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of two CpG sites upstream of CASP8AP2 promoter influences gene expression and treatment outcome in childhood acute lymphoblastic leukemia.
Li ZG; Jiao Y; Li WJ; Deng GR; Cui L; Gao C; Zhao XX; Wu MY; Jia HT
Leuk Res; 2013 Oct; 37(10):1287-93. PubMed ID: 23953914
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia.
Uyen TN; Sakashita K; Al-Kzayer LF; Nakazawa Y; Kurata T; Koike K
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27643535
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia.
Matsushita C; Yang Y; Takeuchi S; Matsushita M; Van Dongen JJ; Szczepanski T; Bartram CR; Seo H; Koeffler HP; Taguchi H
Oncol Rep; 2004 Jul; 12(1):97-9. PubMed ID: 15201966
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL).
Chaber R; Gurgul A; Wróbel G; Haus O; Tomoń A; Kowalczyk J; Szmatoła T; Jasielczuk I; Rybka B; Ryczan-Krawczyk R; Duszeńko E; Stąpor S; Ciebiera K; Paszek S; Potocka N; Arthur CJ; Zawlik I
PLoS One; 2017; 12(11):e0187422. PubMed ID: 29125853
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
9. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.
Milani L; Lundmark A; Kiialainen A; Nordlund J; Flaegstad T; Forestier E; Heyman M; Jonmundsson G; Kanerva J; Schmiegelow K; Söderhäll S; Gustafsson MG; Lönnerholm G; Syvänen AC
Blood; 2010 Feb; 115(6):1214-25. PubMed ID: 19965625
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
12. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia.
Agirre X; Román-Gómez J; Jiménez-Velasco A; Garate L; Montiel-Duarte C; Navarro G; Vázquez I; Zalacain M; Calasanz MJ; Heiniger A; Torres A; Minna JD; Prósper F
Oncogene; 2006 Mar; 25(13):1862-70. PubMed ID: 16314841
[TBL] [Abstract][Full Text] [Related]
13. SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor.
Sakamoto LH; Andrade RV; Felipe MS; Motoyama AB; Pittella Silva F
Leuk Res; 2014 Apr; 38(4):496-502. PubMed ID: 24631370
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia.
Chaber R; Gurgul A; Tabarkiewicz J; Wróbel G; Szmatoła T; Jasielczuk I; Haus O; Lejman M; Rybka B; Ryczan-Krawczyk R; Jaśkowiec A; Paszek S; Potocka N; Arthur CJ; Bal W; Łach K; Kowal A; Zawlik I; Latos-Grażyńska E
Adv Clin Exp Med; 2022 Mar; 31(3):293-305. PubMed ID: 35092653
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group (TCCSG) Study L04-16.
Takahashi H; Kajiwara R; Kato M; Hasegawa D; Tomizawa D; Noguchi Y; Koike K; Toyama D; Yabe H; Kajiwara M; Fujimura J; Sotomatsu M; Ota S; Maeda M; Goto H; Kato Y; Mori T; Inukai T; Shimada H; Fukushima K; Ogawa C; Makimoto A; Fukushima T; Ohki K; Koh K; Kiyokawa N; Manabe A; Ohara A
Int J Hematol; 2018 Jul; 108(1):98-108. PubMed ID: 29589281
[TBL] [Abstract][Full Text] [Related]
17. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
[TBL] [Abstract][Full Text] [Related]
18. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
20. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
